522 related articles for article (PubMed ID: 24857641)
1. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
Oba Y; Lone NA
J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
[TBL] [Abstract][Full Text] [Related]
2. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
Belletti A; Benedetto U; Biondi-Zoccai G; Leggieri C; Silvani P; Angelini GD; Zangrillo A; Landoni G
J Crit Care; 2017 Feb; 37():91-98. PubMed ID: 27660923
[TBL] [Abstract][Full Text] [Related]
3. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell JA; Lee T; Singer J; De Backer D; Annane D
J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
[TBL] [Abstract][Full Text] [Related]
4. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
Jia L; Wang P; Li C; Xie J
Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
[TBL] [Abstract][Full Text] [Related]
5. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
Silverstein DC; Beer KA
J Vet Emerg Crit Care (San Antonio); 2015; 25(1):48-54. PubMed ID: 25655726
[TBL] [Abstract][Full Text] [Related]
6. Vasopressor use in septic shock: an update.
Leone M; Martin C
Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
[TBL] [Abstract][Full Text] [Related]
7. Vasopressors for shock.
Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
[TBL] [Abstract][Full Text] [Related]
8. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
9. Vasopressors and Inotropes in Sepsis.
Stratton L; Berlin DA; Arbo JE
Emerg Med Clin North Am; 2017 Feb; 35(1):75-91. PubMed ID: 27908339
[TBL] [Abstract][Full Text] [Related]
10. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
[TBL] [Abstract][Full Text] [Related]
11. Vasopressor Therapy in the Intensive Care Unit.
Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
14. Vasopressor and inotropic support in septic shock: an evidence-based review.
Beale RJ; Hollenberg SM; Vincent JL; Parrillo JE
Crit Care Med; 2004 Nov; 32(11 Suppl):S455-65. PubMed ID: 15542956
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
Nguyen HB; Lu S; Possagnoli I; Stokes P
J Intensive Care Med; 2017 Aug; 32(7):451-459. PubMed ID: 27189952
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive drugs for vasodilatory shock in ICU.
Holmes CL; Walley KR
Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
[TBL] [Abstract][Full Text] [Related]
17. Adrenergic support in septic shock: a critical review.
Póvoa P; Carneiro AH
Hosp Pract (1995); 2010 Feb; 38(1):62-73. PubMed ID: 20469626
[TBL] [Abstract][Full Text] [Related]
18. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
